Telomir-1 fully reverses oxidative stress in human cells; explores bird flu treatment

Telomir Pharmaceuticals, Inc.

Telomir-1 fully normalized ROS levels in human cell lines, reversing copper-induced oxidative stress.
Provided strong cellular protection against copper toxicity while maintaining cell integrity.
Effective at doses significantly lower than copper levels, indicating unique regulatory mechanism.
Company evaluating Telomir-1 as potential treatment for avian influenza (bird flu) and other viruses.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.